




Development of a High-Throughput
Microfluidic Integrated Microarray for the
Detection of Chimeric Bioweapons
Jay AA West , Kyle W. Hukari, Brent Satterfield, Timothy Sheppod, and Gary Hux
Prepared by
Sandia National Laboratories
Albuquerque, New Mexico 87185 and livermore , Cal ifomia 94550
Sandia is a multiprogram laboratory operated by Sandia Corporation ,
a Lockheed Martin Company, for the United States Department of Energy's
National Nuclear Security Administration under Contract OE-AC04-94-Al85000.
Approved for public release; further dissemination unlimited.
-(rill Sandia National Laboratories
Issued by Sandia National Laboratories, operated for the United States Department of Energy by Sandia Corporation. 
NOTICE: This report was as an account of work sponsored by an agency of the United States Government. Neither the United 
States Government, nor any agency thereof, nor any of their employees, nor any of their contractors, subcontractors, or their 
employees, make any warranty, express or implied, or assume any legal liability or responsibility for the accuracy, completeness, 
or usefulness of any information, apparatus, product, or process disclosed, or represent that its use would not infringe privately 
owned rights. Reference herein to any specific commercial product, process, or service by trade name, trademark, manufacturer, 
or otherwise, does not necessarily constitute or imply its endorsement, recommendation, or favoring by the United States 
Government, any agency thereof, or any of their contractors or subcontractors. The views and opinions expressed herein do not 
necessarily state or reflect those of the United States Government, any agency thereof, or any of their contractors. 
Printed in the United States of America. This report has been reproduced directly from the best available copy. 
Available to DOE and DOE contractors from 
U.S. Department of Energy 
Office of Scientific and Technical Information 
P.O. Box 62 
Oak Ridge, TN 3783 1 
Telephone: (865) 576-8401 
Facsimile: (865) 576-5728 
E-Mail: reuorts@adonis.osti.gov 
Online ordering: htto://www.doe.aov/bridze 
Available to the public from 
U.S. Department of Commerce 
National Technical Information Service 
5285 Port Royal Rd 
Springfield, VA 22161 
Telephone: (800) 553-6847 
Facsimile: (703) 605-6900 
E-Mail: orders@ntis.fedworId.gov 




Printed October 2006 
Development of a High-Throughput 
Microfluidic Integrated Microarray for the 
Detection of Chimeric Bioweapons 
Jay A.A. West, Kyle W. Hukari, Brent Satterfield, Timothy Sheppod, and Gary Hux 
Microfluidics Department 
Sandia National Laboratories 
P.O. Box 969 
Livermore, California 94550-MS9292 
Abstract 
The advancement of DNA cloning has significantly augmented the potential threat of a focused 
bioweapon assault, such as a terrorist attack. With current DNA cloning techniques, toxin genes 
from the most dangerous (but environmentally labile) bacterial or viral organism can now be 
selected and inserted into robust organism to produce an infinite number of deadly chimeric 
bioweapons. In order to neutralize such a threat, accurate detection of the expressed toxin genes, 
rather than classification on strain or genealogical decent of these organisms, is critical. The 
development of a high-throughput microarray approach will enable the detection of unknowns 
chimeric bioweapons. The development of a high-throughput microarray approach will enable 
the detection of unknown bioweapons. We have developed a unique microfluidic approach to 
capture and concentrate these threat genes (mRNA’s) upto a 30 fold concentration. These 
captured oligonucleotides can then be used to synthesize in situ oligonucleotide copies (cDNA 
probes) of the captured genes. An integrated microfluidic architecture will enable us to control 
flows of reagents, perform clean-up steps and finally elute nanoliter volumes of synthesized 
oligonucleotides probes. The integrated approach has enabled a process where chimeric or 
conventional bioweapons can rapidly be identified based on their toxic function, rather than 
being restricted to information that may not identify the critical nature of the threat. 
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Introduction 
In the last fifteen years, technologies surrounding DNA cloning have truly accelerated. In the 
present day, genes from almost any organism (human, bacterial or 'Viral) can be copied and 
inserted into another organism. This is a common practice when researchers are attempting to 
identify whether the function of an unknown gene is related to a disease (i.g. cancer, 
Alzheimer's, heart disease). The bioengineered organisms produced from these experiments are 
often termed "chimeras", named for the mythical Greek monster with the lion's head, goat's 
body, and serpents' tail. This technology, applied with malevolent intentions, poses a significant 
risk to national security. The production of such organisms as bioweapons has been reported [I]. 
The production of the organisms can be achieved with relative ease and, in the coming future, 
may not require Ph.D. level training. Even today, commercialized kits complete with directions 
can be purchased for production of such organisms. 
In the last five years, the development of DNA gene array or "microarray" technology capable of 
detecting thousands of genes in single experiment has rapidly advanced. This technology allows 
for the detection of chimeric bioweapons; however, few if any, microarrays with capability to 
detect biotoxin genes exist. Complicating the use of microarray for biotoxin detection is the 
synthesis of cDNA probes employed to detect the expressed genes of an organism. In its current 
format the synthesis process is long and tedious. Samples isolated for analysis are exquisitely 
sensitive to sample degradation, and the cDNA probe synthesis takes a minimum of two days. 
Microarray analysis of gene expression hinges on the isolation of those expressed genes or 
"mRNA". The current process by which mRNA is isolated is the rate limiting step to performing 
a successful microarray analysis. The system has two major problems for use as a detector for 
bioweapons. First the process to capture the mRNA is labor intensive and requires a minimum of 
four hours to complete. Second, these isolated mRNA are extremely sensitive to degradation 
from a class of enzymes known as RNases. In order to overcome these issues, a microfluidic 
channel will be filled with a polymer based material that has the ability to selectively capture 
mRNA. Replacing test tubes with a closed microfluidic system will solve both of these 
problems. Currently isolation of mRNA is completed on the bench top through a series of steps, 
which include transferring the sample multiple times to new test tubes, containing different 
reagents. By packing a microtluidic channel with the polymer capture material. we will be able 
to change reagents by altering flows through the channel. This advance reduces time, and will 
virtually eliminate sample degradation. RNA in eukaryotic (mammal) cells is degraded by an 
enzyme called RNase. RNases are ubiquitous throughout the body and important for sample 
handling, since they are found on the surfaces of skin, hair and dust. Thus, isolated mRNA 
exposed to air for long period of time will be exposed to RNase, . and be degraded. Capturing 
mRNA's in a microfluidic channel will significantly reduce the exposure of the sample to 
RNases, and will yield improved purity and integrity. Microfluidic control is central to achieving 
the aforementioned goals. Recent work has been focused toward developing polymer 
architectures for effecting microfluidic control [2-41. 
The goal of this project is to streamline this process to capture biotoxin genes, and make 
detection of a complex chimeric bioweapon in a period of minutes. To accomplish this goal, we 
have designed three experimental approaches. First, we will demonstrate that expressed genes 
from chimeric bioweapons can be captured, purified and concentrated on a microfluidic chip; 
second we will synthesize oligonucleotide copies (cDNA probes) of the captured genes using 
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recently developed polymer monolith microvalves. Third, the cDNA probes will be directed onto 
a microarray chip designed to detect biotoxin genes. This report will highlight the work on 
development of a microfluidic devices for microfluidic gene arrays for rapid genomic profiling, 
Preliminary results for preconcentration of mRNA in a porous polymer bed supplemented by a 
numerical analysis of a dimensionless anlaysis of the effect of heat energy convection on a 
microfluidic chip power consumption. 
1. Alibek, K., Biohazard, ed. S. Handleman. 1999, New York: Random House. 320. 
2. Rehm, J.E., T.J. Shepodd, and E.F. Hasselbrink, in Micro Total Analysis Systems. 2001, Kluwar Academic. p. 
227-229. 
3. Kirby, BJ., TJ. Shepodd, and E.F. Hasselbrink, J chromatogr A, 2002. under review. 
4. Hasselbrink, E.F., T.J. Shepodd, and J.E. Rehm, Anal Chem, 2002. under review. 
10 
Chapter 1 
1. Microfluidic gene array for rapid genomic profiling 
Sensitive, accurate detection and portable identification of biological agents is critical to our 
ability to avert wide spread casualties from a bio-terrorist threat. The use of Gene or "micro" 
arrays has become a widespread bioanalytical technique for genomic profiling. Recent advances 
in microarray technology have led to diagnostic applications that are currently being developed 
for the detection of biological pathogens. Two major drawbacks to the current experimental 
format in which these assay are performed are the degradation sensitive long sample processing 
time required for probe generation and the extended time requirement for the aforementioned 
probes to be hybridized to the target DNA on the slide surface. The goal of these studies was to 
develop an array based microfluidic chip and platform that can be adapted to a hand portable 
device. We have also focused our efforts to develop a platform that is easily customized for rapid 
assay development in a wide application space. This will be accomplished by integrating two 
newly emerging and maturing technologies: microarrays and microfluidics. Microarray devised 
devices were first described in 1989 by Ekins et. al. [ l ]  where antibodies were affixed to a solid 
substrate. Subsequent publications Fodor [2] and Schena [3] set the stage for the explosion of 
DNA, gene or Micro array technology. Since these landmark publications, various chip design 
platforms including oligonucleotide, EST, and cDNA have been developed along with an ever- 
expanding number of sources of content or synthesized genes for detection of a particular agent 
or expressed gene. These array technologies vary widely in their format as well as their 
application. High density oligonucleotide arrays, based on Fodor's publication [2] later became 
the base technology for Affymetrix (patent # 5,445,934). These oligonucleotide formats have 
extremely high density, with the capacity to perform measurements on over 350,000 DNA 
elements in a single experiment. While this technology has great measurement capacity, due the 
photolithographic manufacturing process using multiple masks, it is less well suited for 
integration with microfluidic systems. 
A better suited microarray platform for microfluidic integration in a custom or robotically 
spotted cDNA microarray first described by Schena [3]. Sensitive, accurate detection and 
portable identification of biological agents is critical to our ability to avert wide spread casualties 
from a bio-terrorist threat. The use of Gene or "micro" arrays has become a widespread 
bioanalytical technique for genomic profiling. Recent advances in microarray technology have 
led to diagnostic applications that are currently being developed for the detection of biological 
pathogens. Two major drawbacks to the current experimental format in which these assay are 
performed are the degradation sensitive long sample processing time required for probe 
generation and the extended time requirement for the aforementioned probes to be hybridized to 
the target DNA on the slide surface. The goal of these studies was to develop an array based 
microfluidic chip and platform that can be adapted to a hand portable device. We have also 
focused our efforts to develop a platform that is easily customized for rapid assay development 
in a wide application space. This will be accomplished by integrating two newly emerging and 
maturing technologies: microarrays and microfluidics. Microarray devised devices were first 
described in 1989 by Ekins et. al. [I]  where antibodies were affixed to a solid substrate. 
Subsequent publications Fodor [2] and Schena [3] set the stage for the explosion of DNA, gene 
or Micro array technology. Since these landmark publications, various chip design platforms 
including oligonucleotide, EST, and cDNA have been developed along with an ever expanding 
number sources of content or synthesized genes for detection of a particular agent or expressed 
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gene. These array technologies vary widely in their format as well as their application. High 
density oligonucleotide arrays, based on Fodor’s publication [2] later became the base 
technology for Affymetrix (patent # 5,445,934). These oligonucleotide formats have extremely 
high density, with the capacity to perform measurements on over 350,000 DNA elements in a 
single experiment. While this technology has great measurement capacity, due the 
photolithographic manufacturing process using multiple masks, it is less well suited for 
integration with microfluidic systems. A better suited microarray platform for microfluidic 
integration in a custom or robotically spotted cDNA microarray first described by Schena [3] 
This array format has demonstrated good correlation to standard quantitative genetic assays such 
as northern blot analysis [4]. Additionally, using a robotic spotter for array construction offers 
the capability to deposit high density DNA probes in complex architectures, such as microfluidic 
systems that also offer the flexibility to routinely alter content of the device to optimize assay 
conditions rapidly. Low density microarrays have also been recently been developed [5-71. 
These devices make use of a plastic microfluidic channel to effect rapid target to probe 
hybridization times. The current studies were designed to extend this capability to develop on- 
chip sample purification and rapid sample labeling. We also aimed to produce a device that can 
perform these rapid hybridization reactions in a high density microarray format. In order to 
realistically manipulate this technology for practical purposes outside the laboratory, it is crucial 
to first determine the most efficient method of hybridizing a target sequence to a known probe 
sequence. In these experiments, different techniques of labeling mRNA and cDNA, including 
those with Cye dyes and Universal Labeling System (ULS) dyes, were performed. In order to 
further increase the speed in which these type of analyses can be performed, we have designed 
and fabricated a microfluidic microarray that will both decrease sample probe preparation time 
as well as target to probe hybridization time. The development of such devices will allow for the 
miniaturization of microarray instrumentation and make hand-portable microarray techonlogies a 
reality. We first focused on the fabrication of the high density microfluidic microarray that has 
the ability to detect thousands of individual elements in real-time. We have optimized the design 
of this chip to affect reduced hybridization times of target oligonucleotides, eliminate diffusion 
effects to optimize chip-based nucleic acid hybridizations, and to maximize signal to noise ratios 
in order to reduce the optical limit of detection. We have further developed porous polymer 
monolith material for the trapping of mRNA. Using this polymer we demonstrate the rapid 
trapping and release of purified mRNA. To reduce the time required for sample processing, we 
evaluated several commercial nucleic acid labeling protocols. These experiments demonstrate 
that it is possible to generate hybridization ready samples in less than twenty minutes. Finally we 
have developed the first generation fluidic and detection platform. This platform will allow for 
easy use of the fabricated microfluidic chips, and is capable of both performing fluidic control 
elements as well as optical detection. We are currently integrating thermocontrolling capability 
into the device. In this manuscript we demonstrate the individual processes, such as sample 
trapping and rapid hybridization, in order to translate these technologies to a completely 
integrated hand-portable device. 
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1.2 Materials and Methods 
1.2.1 Reagents and supplies: 
The following chemicals were used at various steps of experimentation and were used without 
further purification. 3-Glycidaloxypropyldimethoxymethylsilane, 99% pure Hexanes, 
Ethanolamine, sodium dodecylsulfate (SDS), NaC1, and Ethanol were purchased from Aldrich 
Chemical Co. DEPC water, 20X SSC, 20X SPPE buffers were purchased from Invitrogen. Rat 
oligo test set, spotting buffers, and epoxy coated microscope slides were purchased from MWG. 
PCR clean-up kits were purchased from Qiagen. The microfluidic manifold was constructed on 
site using Delrin and aluminum stock. O-rings were purchased from Apple Rubber. Microfluidic 
fittings made with PEEK were supplied by Sandia National Labs. Ulysis DNA labeling kits were 
purchased from Molecular Probes (Eugene, OR.). CyScribe kits for first strand synthesis and 
cytosine labeled Cye dyes were purchased from Amhersam biosciences. All other chemicals 
purchased were reagent grade or better. 
1.2.2 Microfluidic chip fabrication: 
Devices were optimized by experimental modeling and fabricated using standard 
photolithography techniques. Microfluidic chips were fabricated in fused silica which has the 
advantage of detecting fluorescent spots with a high signal/noise ratio [8]. Fabrication with fused 
silica allows for the use of multiple etch depths to normalize pressure gradients and reduce the 
diffusion distance for target analytes to the probe surface. This reduces hybridization time 
dramatically. Integration of microarrays with a microfluidic device was accomplished by 
designing and fabricating areas for performing sample clean-up, amplification and/or 
hybridization on a single chip. The construction of these arrays was accomplished using a 
multiple depth photolithographic etch process on two separate four inch quartz wafers which 
were subsequently bonded at 1 1 OOoC. Spotting of oligonucleotide probes to the microfluidic 
microarray chips is achieved by use of a robotic spotter that deposits the probes on to a custom 
addressable array. The robotic spotter has micron resolution to position the spotting pens within 
the microchannels. Further details of robotic spotting are provided in U.S. Patent Application 
Serial No. 10/70 1,097, "Micro fluidic Integrated Microarrays for Biological Detection", filed 
November 4,2003. After spotting, the microfluidic chip is cleaned and prepped following 
standard procedures (0.1% sarcosine, next 3x SSC, rinse in deionized water, and immersion in 
ice cold ethanol). Sample oligonucleotide probes, for example commercially available rat DNA 
probes from MWG Biotech (High Point, North Carolina) are attached to the microarray surface 
according to these processes. 
1.2.3 Fluidic hardware and detection plafform development: 
Chip manifolds and supporting hardware were designed and fabricated to interface the 
microfluidic chips using an O-ring face seal. Detection of DNA microarray spots on the 
microfluidic chip was accomplished using a combination of light delivery using fiber 
waveguides with a CCD array detection platform for detection of fluorescent spots on the array 
surface. Using AA battery power to drive an 80mW LED, we are able to deliver light to the chip 
using a custom fabricated fiber bundle waveguide. This waveguide illuminates the channel 
where the DNA microarray is located. Oligonucleotide probes were then deposited in the open 
microchannels using a conventional arraying robot which was controlled by a custom script to 
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allow the deposition of probes in specific locations. These open channels containing the 
covalently linked oligonuceotides were then sealed with a polymer film in order to flow reagents 
to each spot on the device. The microarray is sealed using pressure or adhesion with an optically 
transparent chemically resistant plastic film. The microarray can be adhesively sealed by treating 
a chemically resistant clear plastic sheet (e.g., PDMS) with plasma oxidation to activate surface 
hctional groups. Amineterminated silane was then applied to the plasma oxygen activated 
surface to enable an epoxy-amine sealing reaction between the amine coated surface of the 
plastic film and the epoxy coated fused silica chip. The plastic surface is then bound to the tops 
of the ridges between the channels and top side of the chip. Chips are housed in a manifold 
outfitted with O-ring seals designed to allow for one step chip alignment and to facilitate fluid 
connections to the outside environment. A B a s h  A102fc color CCD camera with a 2: 1 pulled 
fiber optic was purchased *om Videoscope International. Capillary tubing was purchased from 
Polymicro, inc. 
1.2.4 Results for platform development 
The microfluidic chips were designed to accommodate on-chip sample purification, labeling and 
array analysis. To accomplish this, specific regions for sample concentration and arraying are 
designed into a single device. Using this process we were able to create areas on a compact 
device (2.5x3.lcm), which can accommcdate W, patterned monoliths for sample processing 
(figure 1 B&C) and an array-spotting surface for post-fabrication DNA arraying. We designed 
(figure 1A) and fabricated (figure 1B) the first generation of microfludic microarrays. In this 
process, two wafers are etched then, bonded to produce the microfluidic chips. Fabricated Chips 
(Figure 1B) contained an open channel that is etched 15 um into the top surface of the 
microfluidic device (Figure lB&C). This design allows spotting of DNA probes on the 
fabricated chip in an open channel. This architecture serves several purposes. Critical to the 
design of these chips is the ability to robotically spot DNA detection (probes) on the channel 
array surface after fabrication of the microfluidic chip. The shallow serpentine micro channel 
(15um height x 300 um wide) greatly reduces the hybridization time by minimizing the diffusion 
time of the sample and fluidically directing the target past each surface probe. The second set of 
channels are closed and are located between the two wafers. These channels house a monolith 
material that is used for sample purification. 
Figure 1.1. Fabricated micduidic microarray. Masks (A) are designed to optimize hybridization 
conditions such the entire injected sample passes through the serpentine array surface (B&C) 
which is spotted post-fabrication. Using a double wafer etch process areas for containing 
monoliths are isolated from the array surface. 
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The Oligonucleotide trapping monolith is composed mainly of gyclidyl methcrylate (GMA) 
which has a porous structure with roughly 1-3mm pores (Figure 2A). The Gycidyl (epoxide) 
chemistry allows for post functionalizationof the polymerized monolith, as seen in Figure 2B&C. 
Polymerized monolith (Figure 2B), is notfluorescent at 488nm (blue light). In contrast when this 
monolith is post-functionalized (C) with any amine containing molecule (Oregon Green ), the 
monolith appears as a fluorescent signal housed in the capillary (Figure 2B). 
Figure 1.2. Porous polymer monolith are photoinitiated on-chip (A) and bind directly to channel 
walls. These formed monoliths have no native fluorescence (E), but can be post-functionalized 
to incorporate any primaiy amine containing molecule including fluorescent dyes (C). 
oligonucleotides, proteins, etc. 
In order to trap oligonucleotitides the glycidyl methacryalte polymer was functionalized using an 
amine terminated oligodT which contained a C6-linker molecule. Once the monolith was 
polymerized in the channel the oligo dT solution was introduced in a Tris buffer pH 8.3. The 
monolith was then heated to 60°C for thirty minutes in a humid chamber. Unbound oligo dT was 
then flushed out using additional buffer solution. mRNA's (in a TE/SSC buffer) were then 
isolated by using a syringe and syringe pump to deliver flow through the porous polymer 
monolith. The hybridization in the monolith is rapid, occurring in less than two minutes (figure 
3A). After a secondary flushing step using the binding buffer, which does not result in decreased 
fluorescence, the mRNA was eluted using the TE buffer as seen in Figure 3B. 
Figure 1.3. Oligonucleotide trapping monolith: These monoliths were functionalized with an 
Oligo dT. After firnctionalization the labeled mRNA was dissolved in the binding buffer was 
introduced to the column, which became bound (A). After a flushing step (not shown) the 
trapped olignucleotide was eluted from the column using a salt free TE buffer. This entire 
process was complete in two minutes. 
To determine the optimal strategy for fluorescently labeling nucleic acids we tested three 
commercial protocols for use with our system. Depending on the labeling strategy the the 
intensity of the probe hybridization on the microarrays appears to have variability, while the 
patterns of gene expression appear identical between labeling platforms (data not shown). In 
general the direct incorporation of Cye labeled oligonucleotides produced more consistent 
labeled cDNA's. However, as previously reported their appeared to be significant bias in the 
incorporation of the Cy3 vs. Cy5 dye set into the synthesized cDNA's. We also found that this 
labeling technique is not well suited for the labeling of oligonucleotides for the rapid detection of 
genetic signatures. In contrast, we found that the direct labeling of mRNA was an efficient 
technique for obtaining labeled full length nucleic acids. We found that the expression patterns 
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between synthesized cDNAs (figure 4B) and direct labeled mRNA (Figure 4C) were identical. In 
addition, compared to the fnst strand (cDNA) method, the direct labeling of mRNA can be 
accomplished (including clean up) in approximately 10 minutes. 
Figure 1.4. Comparison of first strand cDNA synthesis to direct mRNA labeling. Compared to 
control (A), 0.58lug alexa fluor 532 labeled synthesized cDNAs generated a robust and easily 
detectable signal (B). This was also the case for the direct labeled rnRNAs as 0.372ug alexa 
fluor labeled rnRNA generated a highly detectable gene expression profile (C). 
In order to detect the hybridization of target to probe on the array surface a detection platform 
that utilizes a second collection fiber bundle array is place on the array surface (Figure 5A). 
When the microfluidic chip is illuminated the pattern of the array surface is easily observable 
through the fiber bundle (figure 5B). When this collection fiber bundle is mated to a color CCD 
camera the CCD camera is placed adjacent to the fiber bundle, which is placed on the plastic 
film for imaging the microarray (Figure 5A). Using this system it is possible to detect fluorescent 
spots on the array surface or presence of fluorescent dyes in solution in the channel. To observe 
the hybridization of mRNA in the microfluidic microarray chip, the chip was fist  spotted with 
oligonucleotides. The chip was then sealed using a compression plug which sealed a polymer 
film on the fused silica microarray chip. The labeled mRNA was pre-heated to 9OoC, then 
introduced to the array which was held at a constant temperature of 42°C. The mRNA solution 
was then allowed to stand in the array channel for 5 min, after which addition aliquot of solution 
was passed into the array. After the second incubation period was complete the channel was 
imaged. We found the images collected prior to the hybridization (figure 5C) did not display any 
detectable mRNA target probe hybridizations. In contrast in when fluorescently labeled mRNA 
were passed through the channel were able to detect the hybridization of the target mRNA to the 




. -  
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Figure I .5. Design, fabncation and use of the microfluidic genearray platform. A manifold was 
designed to incorporate the use of excitation source, emission light collection using a CCD 
camera and thermocycling apparatus (A). The manifold and associated parts were fabricated to 
house the microfluidic chip and associated optics (e). Using this system to perform on-chip 
hybridizations we found mRNA labeled with Alexa fluor 647 annealed to the  non-fluorescent 
spotted microfluidic genearray (C) in less 20 minutes (D). 
Our results demonstrate the feasibility of fabricating high density microfluidic genemay chips 
with the capability of performing rapid genomic profiling. The chips are simple to use and easily 
customizable allowing for the rapid alteration of probe content. In addition the entire assembly is 
miniaturized and can be packaged in a hand-portable platform for field analysis of biological 
agents. Previous work by Lenigk, et.al demonstrated the feasibility of the production of 
microfluidic genearrays [7]. In these studies the number of probes was limited to capability of 
the device used to deposit oligonucleotide probes in the microfluidic channels. In the present 
study we have developed a custom spotting scripting software program that allows for the 
deposition of up to 4000 individual elements in selectable positions along the microfluidic 
channel. As demonstrated in the previous studies [6,7], the use microfluidics dramatically 
decreases the time required for the hybridization to the oligonucleotide probes in the 
microchannel. In our studies we have seen hybridization times of less than twenty minutes. In 
addition we have developed an integrated platform for the easy use of the microfluidic chips. 
This system includes the development of sample trapping monolith polymers which have the 
ability to trap and elute fluorescently labeled mRNA in less than two minutes. These polymers 
were similar to those reported for use as a separation matrix for polycyclic aromatic 
hydrocarbons [9-111. During the fabrication of the polymers in this study we took great care in 
preserving the glycidyl functionality of the polymerized monomer. After this initial 
polymerization a second reaction to functionalize the polymer was conducted. We found that we 
were able to extensively functional the surface of this polymer with any primary amine 
containing molecule. In this study this was limited to amine terminated fluorescent dyes, and 
Oligo dT. However, the flexibility of this polymer will make the functionalization of the surface 
chemistry capable of accepting any selective trapping molecule. Such chemistry will allow for 
the use of these columns as pre-selection concentrators for enrichment of a subset of genes of 
interest in following studies. We further evaluated the ability to rapidly label nucleic acids using 
a direct labeling method. We found that the direct labeling method held several advantages over 
the current standard first strand synthesis of cDNAs. First, because the reaction is simple, we 
found far fewer difficulties with contamination of labile mRNA samples. In addition, the method 
was far more rapid, only requiring a maximum of twenty minutes compared to the usual four-six 
hour procedure required for first strand cDNA synthesis. Finally, we found that the using this 
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enzyme free system was far easier to integrate with our assay platform as the labeling of trapped 
mRNA samples can be accomplished by only changing a single solution in the polymer 
monolith. Detection of the amplified microarray spots can be carried out using optical fiber 
bundle arrays, that both transmit and collect light. These fiber bundles deliver high intensity light 
from low power consuming and robust LED's. Detection is carried out with a high resolution 
CCD array capable of collecting signal from all elements on the microarray in parallel. The 
resolution of this CCD array makes it possible to detect all spots in parallel without the need for 
focusing optics. The CCD arraykber bundle is be placed directly onto the arraying surface of the 
chip (figure 1B). This capability will make it possible to detect the presence or absence of 
thousands of threat genes in real-time. In summary, we demonstrate a first generation integrated 
microfluidic high density microarry platform (up to 4000 probes), that has the ability to house 
rapid sample preparation, hybridization, and detection of genomic samples. This allows sample 
preparation of less than 40 minutes including; direct labeling of mRNA's, trapping with porous 
monolith and elution for hybridization. Most importantly this device demonstrates the 
hybridization of mRNA's in a microfluidic channel in less than 20 minutes. In the future we plan 
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Chapter 2
2. Microfluidic polymeric constant flow-through mRNA
sample preconcentrator
Sample preparation can be divided into four major steps, including 1) separation of sample from
matrix through cell lysis and filtration 2) sample analyte preconcentration 3) derivatization and
4) biochemical pretreatment. The actual methodologies in implementing these steps vary
according to the sample type and end analysis. [5] mRNA as a polynucleotide analyte has
particular appeal. It represents the active portion of DNA, or the part of DNA that is actively
engaged in phenotypic expression in an organism. [6] It is readily extracted from the eukaryotic
cellular matrix due to the presence of a polyadenaline tail, thereby limiting competitive reactions
in later analysis.
Most specific mRNA extraction is based on the interactions between a sequence of oligo dT's
and the poly-A tail ofmRNA. The use offunctionalized cellulose to selectively extract
polynucleotides was developed early in the 1960's.[7-10] The integration of polythymine
deoxynucleotides specifically for the purpose of mRNA purification with cellulose columns,
cellulose powders, polymeric beads, and magnetic beads were innovations that followed.[II, 12]
Methods for Polynucleotide extraction in microfluidic devices have been reported primarily
using materials for nonspecific binding such as silica beads,[13] teflon membranes,[14] silica
posts,[15] and gels with immobilized beads.[16, 17] These forms of extraction report somewhat
higher efficiencies and faster extraction times, but none of them have been optimized for specific
mRNA extraction. Further, the fabrication of the devices requires labor intensive packing of
beads or other material and often results in irreproducible construction. A particular difficulty
with the use of these materials is the absence of a stable covalent bond between the deposited
material and the channel walls, which requires the use of frits to contain the deposited material.
An additional difficulty for these methods is the need for multiple solvents or reagents, which
complicate the use of the devices in robust field environments.
Examples of specific mRNA preconcentration and purification on chip are rare. Jiang and
Harrison previously reported the ability to integrate mRNA isolation using magnetic beads on a
micro fluidic device.[18] In these studies the mRNA is first isolated using magnetic beads in a
microfluidic chip, subsequently removed from the stream, and finally, the residue of
nonhybridized material is washed away. This reported device requires 20 minutes of flow time
and offers 26% efficiency. [18]
Recently, functionalized photo-polymerizable monoliths have been used as an alternative to
traditional sample preparation methods for chemicals,[19] polypeptides[20, 21] and
polynucleotides,[22] most of these being used in conjunction with capillary
electrochromatography or HPLC. These materials have been reviewed extensively by Peterson
and Svec.[23, 24] They provide high surface area for adsorption of the analyte ofinterest,[25]
variable pore size and porosity based on concentration and type of porogenic solvent,[ 19] and
are easily and cost-effectively created inside of microfluidic channels through UV-light
exposure. They also exhibit good surface adhesion and make even contact with channel
walls. [26]
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Despite these advances, to date there are no sample preparation devices which truly take 
advantage of current technology and trends for preconcentration and purification of mRNA. In 
this paper, we report an mRNA sample preconcentration method which allows for facile 
incorporation into a microfluidic detection unit, and furthermore allows for constant flow 
through binding kinetics with the use of a single solvent. Using a photo-initiated monolith that is 
polymerized and functionalized in-situ, we were able to take advantage of the large surface area 
and controllable pore size inherent to monoliths. High efficiencies and fast hybridization times 
predict that the oligonucleotide functionalized porous polymer monoliths will be an ideal method 
for mRNA sample preparation in microfluidic devices. 
2.1 Experimental 
2.1.1 Reagents and supplies: 
The following chemicals were used at various steps of experimentation and were used without 
further purification. 3 -Glycidylpropyldimethoxymethylsilane(GMA), 
Ethvlenerzlvcoldimethacrylate (EGDMA), 99% pure Hexanes, Ethanolamine, sodium 
dodecylsulfate (SDS), NaC1, and Ethanol were purchased from Aldrich Chemical Co. DEPC 
water, 20X SSC, 20X SPPE buffers were purchased from Invitrogen. PCR clean-up kits were 
purchased from Qiagen (Valencia, CA). The microfluidic components were constructed on site 
using Ultem (polyetherimide, GE Plastics, Southfield, MI). O-rings were purchased from Apple 
Rubber. Microfluidic fittings made with PEEK were supplied by Sandia National Labs or 
purchased from Upchurch Scientific (Oak Harbor, WA). Ulysis DNA labeling kits were 
purchased from Molecular Probes (Eugene, OR.) and used to label mRNA as suggested by the 
manufacturer. All other chemicals purchased were reagent grade or better. 
2.1.2 Porous polymer monoliths: 
Trapping of target oligonucleotides was accomplished using a UV cured porous polymer 
monolith which was fabricated in a fused silica capillary. Briefly, capillaries (Polymicro, 
Technology, Phoenix AZ) were pretreated with a mixture of 50% v/v distilled deionized water, 
30% glacial acetic acid, and 20% 2-6030 (Dow Corning Midland MI). The solution was used to 
fill the capillaries which stood for an hour. Chips were then flushed with filtered buffer (1OmM 
NaH2P04 Buffer, pH 7.0) and dried. Monoliths are readily created by choosing a crosslinker, a 
functional monomer, a porogenic diluent, and a photo-initiator. For the se experiments the 
monomer mixture was optimized to contain (added in this order) 12.5 % v/v lOmM NaH2P04, 
pH 7.0, 12.5 % ethyl acetate, 40% methanol, 10.5 % GMA, 24.5 % EDGMA, also containing 
either 2.5 mg Irgacure (Ciba Specialty Chemicals, McIntosh, AL) or 5.0 mg 
Azobisisobutyronitrile (AIBN). The solution was vortexed until the initiator was solublized and 
was passed through a hydrophobic filter. Prior to polymerization the capillary is flushed with the 
sodium phosphate buffer. The capillaries are then filled, and photo initiated at 365 nm using 
either a UV crosslinking oven (Spectronics Corporation, Westbury, NY) or using an OptiluxTM 
501 UV dental curing gun. Devices and capillaries were masked where appropriate. 
2.1.3 Functionalizing PPM 
After porous polymer monoliths are formed in the capillary, the material is flushed with 
phosphate buffer. These monoliths can be stored for several days or immediately functionalized 
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with a variety of chemistries. For our purposes we then either functionalized the PPM with 
primary amine terminated fluorescent dye molecules, typically performed in pure acetonitrile, or 
functionalized the polymers with the oligonucleotide complete with a 5’NH3-C6 linked Oligo dT 
(30 or 40mer) having a 6-carboxyfluorescein covalently linked to the oligonucleotide near the 5’ 
terminus. To perform functionalization, oligo dT (10-20ug/ul), was dissolved in a buffer 
containing 3X SSC and 0.05-0.1% SDS. The oligonucleotides were then denatured before 
introducing them to the native PPM. The covalent attachment of oligonucleotides was optimized 
at 120°C for 30 minutes. The attachment of the oligo dT was confirmed by imaging the 
fluorescently derivatized column. 
2.1.4 Hybridization of mRNA to Oligo dT Monolith: 
Stopped flow mRNA hybridizations were carried out by first performing a blocking step to 
prevent nonspecific binding using a blocking buffer containing 5-1OmM Tris buffer pH 9.0, 
0.05-0.1% SDS, 0.lmM BSA and ethanol amine. After blocking was complete 0.5-1.0 UL of 
mRNA containing sample was pumped through the capillary in order to remove the 
concentration gradient appearing from reagent mixing in the microfluidic T. During loading, the 
capillary was maintained at a temperature well above the theoretical melting temperature for 
polyadenaline and polythymine hybridization, to avoid mRNA annealing. Once the mRNA’s 
were loaded, the capillary was removed from heat for a period of time ranging from 2- 
600seconds. After this incubation at room temperature, the monolith was flushed with 5uL of 
washing buffer and imaged using a fluorescent scanner. The average fluorescent intensity across 
the length of the capillary was noted for each hybridization time. A relative efficiency was 
calculated for each trial by using the expression (W-C)/(L-C), where W is the fluorescent 
intensity of the washed and trapped mRNA, L is the loaded intensity and C is the control 
intensity with no mRNA. Bound mRNA’s were then eluted with <5uL of buffer over 2 minutes 
at 90°C by placing the capillary directly on the heating block. 
2.1.5 Continuous flow mRNA hybridizations: 
These experiments were performed as described for the stopped flow hybridization, with a few 
minor alterations. We maintained the underside of the fitting at 95°C (using this temperature 
ensures compatibility with thermoelectric cooler limitations and is standard with PCR melting 
temperatures). The temperature on the top side of the fitting was measured with a k-type 
thermocouple and reported as 50 degrees C. Since steady-state thermal conduction over a 
homogenous material is linear in nature,[27] the middle portion of the microfluidic fitting could 
be calculated as approximately 72.5 degrees C. The flow rate was set at OSuL/min, providing an 
average fluid velocity of 3mm/s, or approximately 10 seconds of contact time for the mRNA to 
hybridize with the oligo dT’s inside the column before passing through the other side. Following 
mRNA preconcentration, the capillary was immediately rinsed, with no incubation time between 
steps. 
2.1.6 Imaging 
Unless otherwise stated, all scanner images were prepared the same to not lose comparative 
qualities. The pictures within each figure were taken with the same scanner settings and were 
processed in Microsoft Office Picture Manager by manually adjusting the brightness and contrast 
and the color in order to convert from gray scale to color images. The brightness was increased 
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to 40, contrast to 80 and midtones to 100 for each picture. Then the color was altered by 
increasing the amount to 100 and the saturation to 100. The hue of the DNA wavelength pictures 
was changed to 100 to produce the p e n  tint and the hue of the mRNA wavelength pictures was 
left at 0 to achieve the reddish tint. 
2.2 Results & Discussion 
We performed a variety of experiments to determine the optimal scheme for the deposition of 
glycidyl containing PPM in the capillary. These experiments terminated in the polymerization of 
a porous material that readily allows the attachment of various amine containing compounds 
(figure 2.1). The nodules in these polymer materials appear to be bound to the channel wall 
(figure 2.1A). We found that the polymerized monoliths were rigid and similar to previous 
studies,[20,26] mitigating the use of frits to contain the polymer in the capillary channel and 
allowed the deposition of the polymer in a discrete location, such as in a microfluidic device. 
These polymers as seen in Figure 2.1A, have a very homogenous consistency, with a rough pore 
size of 2 to 3 um in diameter. The pore size can be optimized within the monolithic structure to 
allow uL./min flow at pressures ranging h m  0 to over 2000 psi simply by varying the 
constituents in the porogenic solvent. For ease of use, we created monolithic structures which 
allowed flow at pressures under 200 psi by selecting methanol as the porogenic solvent. The 
monolith mix was photopolymerized inside a 75um inner-diameter (id) silica capillary. We 
estimate 65% porosity, in a polymer of 75um id and 3 cm in length. The total porous volume 
(porosity x capillary volume) is approximately 84 nL, assuming that full polymerization of all 
constituents occurred. 
Figun, 2.1. Photopolymerization and post-functionalion of the mondith material: Reveals 
SEM image of polymer msistency in the Capillary (A) in addition to a high gain image with no 
fluorescent marker (6) in contrast to a low gain image with Oregon green covalently bound to the 
PPM (C). 
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Following the optimization of the monolith material, we then optimized the ability to post- 
functionalize the materials. The GMA monomers selected for these studies allowed the 
attachment of a variety of biological entities provided the molecule could perform a nucleophilic 
attack on the intact epoxide ring on the synthesized PPM. Prior to functionalization there was no 
discernable fluorescent signal from the PPM. In figure 1B the gain was increased to allow the 
imaging of the capillary, which can be seen upon closer examination. To optimize the conditions 
for functionalization, we initially made use of a fluorescent dye. Oregon green caverdine was 
employed due to its high fluorescent intensity and the presence of a terminal amine on the dye 
molecule, enabling direct covalent reactivity with the GMA. In order to functionalize the PPM, 
the column was filled with Oregon Green caverdine and allowed to stand over night at room 
temperature. After this overnight incubation the columns were extensively flushed, typically 
three hours, to remove unbound species. Figure 2. IC is a fluorescent image of a capillary after 
functionalization with Oregon Green. In contrast to the control image (figure 2.1B), an intense 
fluorescent image is present. To ensure the chemistry was stable these columns were flushed (in 
the dark) in a variety of solvents and pH conditions for as long as one week. Continuous flushing 
for over a week, with a range of pH's from three to nine could not remove the Oregon Green 
once bound. This excessive flushing, however, was not necessary to remove the unbound 
species. It was determined that as little as 1 -2uL of buffer would remove the excess or unbound 
fluorescence. Functionalized monoliths also maintained fluorescence for more than 6 months, 
demonstrating the robustness of the polymer once functionalized, which is ideal for the rugged 
requirements of field tests. 
Having optimized the attachment of organic compounds to the polymer we then focused on the 
ability to functionalize the polymer monoliths with oligonucleotides (figure 2.2). As with the 
Oregon Green functionalization, the optimization of oligo dT binding was perfonned under 
stopped flow conditions in a 75pm i.d. capillary (figure 2.2A). The attachment of an 
oligonucleotide (30mer Oligo dT labeled with FAM) on the polymer was carried out in a range 
of temperatures and incubation times to optimize the functionalization. Initially, the oligo was 
introduced and allowed to incubate for 30 minutes at 60"C, and then flushed with 5uL of 
phosphate buffer. As noted previously, only 1 -2uL of buffer were required to remove the 
unbound species. Each subsequent polymer was also flushed with the same amount of fluid 
following oligo dT incubation. As seen in figure 2.2B an extremely faint, if not undetectable, 
amount of Oligo dT is attached to the PPM. When the incubation time was extended to 60 
minutes (figure 2C) there appeared to be an increase in the fluorescent intensity of the 
functionalized polymer. Beyond 60 minutes the incorporation of the oligo dT was not 
significantly improved with longer incubation times at this temperature (p = 0.179). In contrast, 
raising the temperature demonstrated the most dramatic effect on functionalization of the PPM. 
When the temperature of the functionalization reaction was increased to 90°C from 60°C the 
amount of fluorescent signal doubled with a p value of 0.838 for a t-test with the hypothesis that 
the increase in signal intensity at 90°C was equal to twice the increase in signal intensity at 60°C 
(figure 2.2D). As seen with the lower temperature, oligo binding increased over time. Between 
30 and 60 minutes, the binding of the Oligo at 90°C was significantly increased by 1.23 units of 
fluorescent intensity per minute (significance of coefficient p = 0.059) more than doubling the 
fluorescent intensity seen at 30 minutes of incubation (figure 2.2E). This increase while much 
greater over time than the lower temperature also reached a maximum at 60 minutes with no 
further increase in oligo binding observed at time points greater than 60 minutes (p = 0.91 1). 
Maximal binding in the shortest time was found when the temperature of the functionalization 
was raised to 120 degrees. In contrast to previous trials at lower temperatures, increased 
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incubation did not result in increases (compare figures 2.2F & 2.2G) in fluorescent intensity (p = 
0.776). The observed plateau in fluorescent intensity was not attributed to signal saturation since 
higher fluorescent intensities were observed on the capillaries prior to washing off the excess 
oligo dT. 
Figure 2.2 contains magnified images of single capillaries, and as such is only representative 
data. Multiple capillaries were functionalized under each of the foregoing conditions. The 
intensity, representing oligo dT binding, spanning the length of the entire capillary image was 
averaged with each capillary for a given experimental condition. These averaged intensities 
taken with an 8-bit tricolor resolution were then plotted in a contour plot as shown in Figure 3. 
The fluorescent intensity at 9OoC reaches a maximum around 60 minutes, which maximum is 
equivalent to the intensity of a capillary incubated at 120°C for either 30 minutes or 60 minutes. 
Thus, binding continues to increase with time after the first 30 minutes for temperatures below 
about 113°C and do not for temperatures over this. The average fluorescent intensity of 
capillaries bound at 12OOC for 30 minutes were statistically identical to the average intensity of 
those incubated for 60 minutes, p = 0.776. For all further experimentation, the optimal binding 
conditions thus determined were used, that being 30 minutes at 120 degrees C. Higher 
temperatures and longer times apparently would not increase binding and would only increase 
the possibility of DNA or polymer degradation. Additional bindings under similar conditions did 
not result in significant increases in oligo functionalization. 
Figure 2.2. Oligo dT binding optimization: Shows a light microscope image of the capillary with 
monolith (A) together with oligo binding intensity for different imes and temperatures. The 
images are for 60°C for 30 minutes (B) and 60 minutes (C), 90°C for 30 minutes (D) and 60 
minutes (E), and 120°C for 30 minutes (F) and 60 minutes (G). 
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Figure 2.3. Contour plot of oligo binding: Reveals the conditions under which maximal binding of 
oligo dT’s to the PPM occur. Incubation at either 90°C for 60 minutes or 120’C for 30 minutes 
results in maximal binding. 
Like the dye functionalized PPM, we found that the Oligonucleotide functionalized monoliths 
were exceptionally stable both with various buffers and solvents. Over 20OuL of pH 9.0 blocking 
buffer was flushed through the column at 12OOC for more than an hour with minimally detectable 
oligo elution or degradation as indicated by fluorescent intensity and ability to trap and elute 
mRNA. In addition we found the functionalized columns were stable over time, as many of these 
devices have been stored dry over several weeks without significant decreases in fluorescent 
intensity. Taken together these results indicate that the functionalized polymers will be stable 
under the most severe of conditions, as required for field applications. 
The primary objective of these studies was to demonstrate the ability to trap, concentrate, and 
select specific nucleotide sequences. With the monolith optimally functionalized, we then tested 
the ability of the Oligo dT columns to trap and release mRNA. An experimental configuration 
was set up using a microfluidic junction and syringe pumps to allow repeatable experimental 
conditions. The T-junction had two points of entry and one exit. In this arrangement one 
connection was used to load the mRNA samples, while the other, which contained the sample 
buffer only, was used to wash and elute the loaded sample. To the third connection a capillary 
functionalized with Oligo dT was inserted. This allowed precise control over the amount of time 
allowed between load, wash and elution steps. A heating block, verified at 90°C with a 
thermocouple, was placed witbin easy access to be able to apply and remove heat to the capillary 
virtually instantaneously. Figure 4 shows the results of injection of a single capillary volume of 
mRNA’s and their subsequent trapping and release. Prior to loading the capillary with labeled 
Alexa fluor 647 mRNA, the capillary was imaged (Figure 2.4A). No flourescence was detectable 
in the absence of labeled mRNA. The gain and contrast were set so that the control would barely 
be visible and were kept constant for the remaining images. Immediately following the imaging 
of the unloaded capillary, approximately 1 ng (lOOnh4) of labeled mRNA was then loaded into 
the capillary. The device was in contact with the heating block set at 90 degrees C to allow for 
denaturation of the nucleic acids (figure 2.4B). The capillary was then allowed to stand for 10 
minutes after which the unbound material was flushed out of the column using 5pL of lXSSC 
buffer (figure 2.4C). Compared to control, the bound mRNA (figure 2.4C) generated average 3 
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fold fluorescent signal increase (figure 2.4E). The fluorescence of the bound mRNA was 
considerably lower than imaged for the loading solution (-3 fold). In order to insure that the 
wash volume was sufficient, the column was flushed with more than 60 uL for the duration of an 
hour with no change in fluorescence. It has been ascertained that 1-2uL is sufficient to wash the 
mRNA in capillary. Following washing, the mRNA was eluted at 90°C with 2.5uL of lxSSC in 
5mM TE buffer over one minute (figure 2.4D). The fluorescent intensity of the eluted column 
appears to be the same as that of the control, indicating a nearly complete removal of bound 
mRNA h r n  the capillary. However, as these images represent discrete segments of a capillary, 
the full range of intensities across the capillary were plotted against the capillary position in 
Figure 2.4E. As previously described the control had a low, almost undetectable, fluorescence 
intensity over the entire column. When the column was loaded we noted a high intensity 
fluorescence profile that appeared to decrease along the column length. This was a phenomena 
discovered to be due to a more dilute concentration caused h m  reagent mixing in the 
microfluidic junction. Further experiments allowed for a larger volume of mRNA's to be pumped 
through the microfluidic junction in order to eliminate this effect. The variation observed in 
concentration did not appear to effect mRNA hybridization. This high intensity signal decreased 
when the column was washed removing the unbound mRNA. We noted the intensity gradient 
observed with the loaded column was absent and the fluorescent intensity of the boundmRNA 
appeared to be consistent across the length of the monolith filled channel. Finally when the 
column was eluted the overwhelming majority of bound mRNA was denatured and removed. 
Figure 2.4E reveals that complete elution did not occur, but a majority of mRNA was 
successfully recovered. 
I 
Figure 2.4. Batch trapping of mRNA: Demonstrates ability of PPM to trap mRNA from a single 
capillary volume. Shows the control with no mRNA (A) as compared with the loaded intensity 
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(B). the washed fluorescence (C), and the eluted intensity (D). While the  images are only 
representative segments of the capillary, figure 2.4E is a graph of fluorescent intensity across 
the entire length of the capillary. 
Although the trapping and elution of mRNA's &om the monolith may seem self explanatoy, we 
did note conditions which inhibit successful mRNA preconcentration and purification. For 
example, failure to denature the mRNA inhibits hybridization of the sample analytes to the Oligo 
dT functionalized porous polymer monolith (figure 2.5). In addition, failure to properly block 
the column has repeatedly resulted in irreversible binding to the polymer monolith (data not 
shown). Successful blocking of the column was best performed using a solution containing both 
ethanol amine and bovine serum albumin. Finally, selecting a proper salt concentration can 
facilitate fmding a single binding/washing/elution buffer, thereby solving one of the many 
problems of automated microfluidic analysis in determining how and where to store the 
multitude of reagents.[5] 
' 
Figure 2.5. Failure to denature mRNA: Shows the  control with no mRNA (A) as compared with 
the loaded intensity (B) and the washed fluorescence (C). There IS no significant amount of 
trapping when mRNA is not properly denatured. 
Having optimized the conditions for optimal binding, washing and elution of purified mRNA we 
then focused on determining and optimizing reaction kinetics (figure 2.6). We found in our 
experiments there was no visible trend in hybridization efficiency over time. In fact, the 
efficiency of trapping with a hybridization time of ten minutes appears to be the same, or perhaps 
a little less than the efficiency of trapping with an incubation time of two seconds. The other 
trials with hybridization times of 5 ,  10, 15,30,60, and 120 seconds together with the previously 
mentioned two trials appear to form a linear pattern with no slope (significance of coefficient 
from 2 to 120 seconds, p = 0.962) scattered ahout an average efficiency of 33%. The lack of any 
increase in efficiency with time demonstrates hybridization is complete at the initial time point 
measured, two seconds. 
The exact same procedure was used to test and measure 40mer oligo efficiencies. The 40mers 
also demonstrated a linear pattern of efficiency with no apparent slope (significance of 
coefficient from 2 to 120 seconds, p = 0.867). In contrast to the 30mer Oligo dT, the scatter plot 
is centered about an efficiency of 50%. The ratio of the average efficiencies demonstrates that 
the 40mer functionalized monolith binds with 1.5 times the efficiency of the 30mer characterized 
monolith. We believe the results are due to a greater change in free energy than the 30mer in 
hybridization with its RNA counterpart. 
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Figure 2.6. Kinetics of DNA hybridization: Experiment for a capillary containing 30mer and 
40mer oligo dT's. The 30mer and 40mer oligo dT's are represented by the blue diamonds and 
range from 3040% effiaency over 8 trials witfi no significant change for increased hybridization 
times. 
Since both the 3Omer and 4Omer functionalized polymers demonstrated linear binding 
characteristics with a nonsignificant slope, it can be concluded that hybridization is already 
complete by the time the monoliths are washed, over a range of nucleotide probe lengths. 
Therefore, the kinetics of hybridization inside of the polymer are rapid, fast enough to allow 
constant flow through binding. 
We then optimized the PPM for continuous-flow mRNA purification and sample 
preconcentration. For these experiments the intensity gain was set to the highest level without 
saturating the CCD array of the scanner during preconcentration (figure 2.7). In addition, 
contrasting the previous experiments where the capillary was heated, the microfluidic T was 
placed over a heater at 95OC (figure 2.7F). This allowed for RNA denaturation prior to 
introduction to the Oligo dT column. Similar to the previous experiments, the unloaded capillary 
appeared to contain no detectable fluorescence (figure 2.7A). To acquire the loaded image, the 
capillary was again heated to 95°C and loaded with the same solution used in figure 2.4B. In 
contrast, to figure 2.4B the fluorescence in figure 2.7B (the same solution) waq nearlv 
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undetectable, due to the decreased gain settings. The microfluidic fitting was then placed on the 
TEC and the mRNA solution was pumped through the heated fitting into the capillary. We 
observed in these experiments a small portion of capillary with no fluorescence, followed by an 
intense segment of brightness, which then gradually tapers down to a more faint level of 
fluorescence. The intensity of the fluorescence in the brightest region was approximately 30 fold 
higher than the initial loaded volume (figure 2.7B&E), demonstrating the preconcentration of 
mRNA during constant flow. The efficiency as the ratio of trapped mRNA over loaded mRNA 
was approximately 80%. Not only was preconcentration achieved, but the capture efficiency was 
greater for the constant-flow set up than it was for the batch reaction. This is significant as it will 
eventually lead to the ability to work with extremely dilute solutions and to concentrate them to a 
point that is detectable in real time. Furthermore these concentrated mRNA's could be eluted in a 
discrete volume of solution, only requiring 1 .O uL of buffer at 95"C, to release the entire sample 
(figure 2.7D), resulting in fluorescence measurements comparable to the control. As the images 
in figure 2.7 represent only discrete segments of the capillary, Figure 2.7E shows the intensity of 
the capillary along a larger portion of its length. A large fluctuation of mRNA binding is seen 
over the length of the capillary. Along the first few millimeters, the intensity is nearly identical 
to the control with no mRNA. The next few millimeters exhibit concentration around 30x of the 
initial concentration. Finally, the last 2.5cm (only half centimeter shown) fall to a constant 
intensity just over the initial concentration. These results were found to be identical over a 
number of Oligo dT functionalized capillaries (n>lO). We believe the explanation for these three 
regions of differential binding in capillary lies with the temperature gradient within the 
microfluidic fitting and capillary. The first few millimeters of capillary are confined within the 
microfluidic junction or T that is heated to 72 degrees C at its center. This temperature is above 
the melting temperature, and consequently no mRNA's bind. The next section of the capillary is 
within the microfluidic fitting sticking out from the junction (see Figure 2.7F). This portion is 
not touching the TEC and is somewhat cooler than the microfluidic junction. Nevertheless, as it 
is in contact with the microfluidic junction, some heat is transferred along its length, resulting in 
a temperature that is still higher than the temperature of the surroundings, yet lower than the 
melting temperature. It is inside this fitting that the melting temperature is crossed, as exhibited 
by the sharp spike in fluorescent intensity in Figure 2.7E. As the temperature continues to fall 
across the length of the fitting, the efficiency of mRNA capturing begins to decrease. Finally, as 
the capillary emerges from the fitting, the temperature drops almost instantaneously to room 
temperature, reducing the mRNA hybridization efficiency for the remainder of the capillary. 
This explanation seems reasonable based on previous work on the thermodynamic nature of 
nucleic acid hybridizations.[7] Our results are similar to those found by Jiang and Harrison, et a1 
who reported 26% efficiency in 20minutes of run time, not including denaturing and subsequent 
elution, along a 2.9cm channel that was 200um wide and 30um deep. They concluded from their 
results that a more efficient capture bed was needed to improve efficiency. [ 181 Here we report 
80% capture efficiency for the flow through preconcentrator, with potential for near 100% with 
proper temperature optimization across the entire length of the capillary, in a photo-initiated 




Figure 2.7. Constant-flow preconcentration: Depicts PPM ability to preconcentrate mRNA The 
images are for the control with no mRNA (A), single volume of mRNA (B), washed following 
preconcentration (C), and eluted (D). While the images are only representative segments of the 
capillary, figure 2.7E is a graph of fluorescent intensity acmss the entire length of the 
capillary.2.7F shows the capillary set up with the microRuidicT resting on the TEC. 
Having demonstrated the efficacy of preconcentration of purified mRNA we then tested the 
selectively of the hybridization reaction in a large background of DNA. Using a mixture of 
Alexa fluor 532 labeled DNA 4ug/d and Alexa fluor 647 labeled mRNA 0.85ug/d, we tested 
the ability of the Oligo dT functionalized column to selectively trap mRNA. As seen in figure 
2.8A&B, the control images showed a low level of fluorescence in their respective channels. 
When one capillary volume of the sample solution was preloaded on to the capillary an intense 
fluorescent image was present in the green (DNA) channel, and significantly lower in the red 
(mRNA) channel (Figure 2.8C&D). Preconcentration of the mRNA was then performed (figure 
2.8E&F). After passing 160 UL of the sample solution through the monolith trapping column the 
image collected from the green (DNA) channel (Figure 2.8E) appeared similar to the preloadeed 
column, while the fluorescence in the red (mRNA) channel increased dramatically (Figure 2.8F). 
The loaded column was then washed with an additional volume. of sample buffer which removed 
the unbound DNA (Figure 2.8G), while the bound mRNA (Figure 2.8H) remained hybridized on 
the functionalized column. Similar to previous experiments the bound mRNA was then eluted by 
increasing the temperature on the monolith column. This resulted in a dramatic decrease in the 
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Figure 2.8. Selectivity of PPM preconcentration: Shows the selective adsorption of mRNA (red, 
right side of figure) over cDNA (green, left side of figure) for preload (ABB), a single volume 
(CBD), post preconcenlration (EBF), washed (GBH) and eluted (l&J). Although DNA is 
significantly more concentrated than rnRNA. only mRNA is left after wash step. 
We believe that our results demonstrate the potential use of these materials as a scnsitive single- 
stcp, real-time dctection system. The 30mer kinetics experiments captured approximatcly 0.3ng 
of mRNA in 3cm of microfluidic capillary. This amount of mRNA contributed to a signal to 
noise ratio of nearly 50: I .  Assuming linearity of fluorescent intensity increase between 0 and 
Ing mRNA, we could theorctically detect as little as 18pg of mRNA in a 3cm capillary or 60fg 
(0.06amol or 36,000 molecules) mRNA in a 1OOmicron segment of capillary with a 3: I signal to 
noise ratio. We used a mRNA concentration of lOOnh4 in our experiments, however, as noted 
previously we can prcconcennate mRNA at least 30x yielding a potential detection limit around 
20fM. We also report the ability to reuse the sample preconcentraton. We have consistently used 
the columns for 10 or morc trials, verifying completion of elution after each mal. During the 
course of the 10 trials, thc efficiency did not decrease, and the baseline fluorescence after elution 
did not change noticeably (data not shown). 
2.3 Conclusions 
In conclusion, we have confirmed our original goal to create a photo-polymerized monolith in- 
situ, which allows constant flow sample preconcentration with temperature controlled binding 
and elution. We have discovered the means whereby trapping can be maximized and are taking 
the next steps by developing devices which will allow more precise temperature control inside 
different regions of the monolith. Other areas that still need to be explored include examining the 
efficiency of and overall binding capacity of the monoliths under competitive binding 
conditions. The rate of nonspecific binding needs to be identified as well. The potential of the 
monolith is great in that it allows low pressure installation of a binding substrate without need of 
a f i t  to contain it. It has the potential to bind as much mRNA with similar or higher efficiencies 
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